Aktiespot

Beximco Pharmaceuticals PLC. (BEXIMCO PHARMACEUTICALS PLC GDR) Aktie

BXP.L

Geschlossen
£42.500.00 (0.00%)
Chart wird geladen...

BEXIMCO PHARMACEUTICALS PLC GDR

Eröffnung42.00
Hoch42.00
Tief42.00
Volumen1.14M
P/E4.72
Marktkapitalisierung189.6M
52-Wochen-Hoch52.33
52-Wochen-Tief0.43
Durchschn. Volumen
DividendeN/A
Beta0.24
EPS0.09

Über Beximco Pharmaceuticals PLC. (BEXIMCO PHARMACEUTICALS PLC GDR) Aktie

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Unternehmensinformationen

Börse: LSE (LSE)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
19 Dhanmondi R/A
1205 Dhaka, Bangladesh
Telefon: + 880 2 5861 1001

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: